Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation.
Lukes J Jr, Danek P, Alejo-Valle O, Potuckova E, Gahura O, Heckl D, Starkova J, Stary J, Mejstrikova E, Alberich-Jorda M, Zuna J, Trka J, Klusmann JH, Zaliova M.
Lukes J Jr, et al. Among authors: gahura o.
Leukemia. 2020 Sep;34(9):2503-2508. doi: 10.1038/s41375-020-0769-1. Epub 2020 Feb 24.
Leukemia. 2020.
PMID: 32094462
No abstract available.